4.7 Article

System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 224, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2021.113683

Keywords

Diaminopurine; Broad-spectrum antivirals; Dengue; Zika; West nile virus; Influenza; SARS-CoV-2

Funding

  1. Ministero dell'Istruzione, dell'Universita della Ricerca Italiano (MIUR), PRIN 2017 project [2017BMK8JR]
  2. Tuscany region, project Tuscany Antiviral Research Network - TUSCAVIR.NET (Bando Ricerca Salute 435, 2018)
  3. Sapienza University of Rome
  4. AIRC: MFAG [18811]
  5. Fondazione Banca del Monte di Lombardia

Ask authors/readers for more resources

The global spread of viruses underscores the need for new antiviral drugs. This study identifies a promising broad-spectrum antiviral compound with high potency against multiple viruses, including SARS-CoV-2. The compound exhibits multi-target effects on virus replication and holds potential for treating diverse viral infections.
The worldwide circulation of different viruses coupled with the increased frequency and diversity of new outbreaks, strongly highlight the need for new antiviral drugs to quickly react against potential pandemic pathogens. Broad-spectrum antiviral agents (BSAAs) represent the ideal option for a prompt response against multiple viruses, new and re-emerging. Starting from previously identified anti-flavivirus hits, we report herein the identification of promising BSAAs by submitting the multi-target 2,6-diaminopurine chemotype to a system-oriented optimization based on phenotypic screening on cell cultures infected with different viruses. Among the synthesized compounds, 6i showed low micromolar potency against Dengue, Zika, West Nile and Influenza A viruses (IC50 = 0.5-5.3 mu M) with high selectivity index. Interestingly, 6i also inhibited SARS-CoV-2 replication in different cell lines, with higher potency on Calu-3 cells that better mimic the SARS-CoV-2 infection in vivo (IC50 = 0.5 mu M, SI = 240). The multi-target effect of 6i on flavivirus replication was also analyzed in whole cell studies (in vitro selection and immunofluorescence) and against isolated host/viral targets. (C) 2021 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available